Psychiatric Comorbidities in HIV-Positive Patients: A Literature Review
DOI:
https://doi.org/10.12775/JEHS.2025.81.66778Keywords
HIV, depression, PTSD, anxiety, substance use disorders, neurocognitive disordersAbstract
Background People living with HIV (PLWH) experience psychiatric comorbidities far more frequently than the general population, with prevalence estimates ranging from 1.5 to 8 times higher. These mental health conditions substantially impact treatment adherence, viral suppression, and overall quality of life.
Aim This literature review aimed to provide an updated, comprehensive overview of psychiatric comorbidities in people living with HIV and their underlying biological and psychosocial mechanisms.
Materials and Methods This article systematically reviews the existing literature on psychiatric comorbidities among HIV-positive patients. A comprehensive database search was conducted using Web of Science, PubMed, and Google Scholar. The bibliographies of cited works were also reviewed. The literature review and article selection process concluded in October 2025.
Results To the most prevalent psychiatric disorders among PLWH belong depression (31%), posttraumatic stress disorder – PTSD (28%), anxiety disorders (20-40%), substance use disorders – SUD (40-74%), and HIV-associated neurocognitive disorders – HAND (45%). Psychiatric comorbidities in PLWH result from complex interactions between biological mechanisms – including HIV's affinity for neural tissue, chronic neuroinflammation mediated by cytokines such as IL-6 and TNF-α, and reduced monoamine availability – and psychosocial factors, particularly internalized stigma, discrimination, and trauma related to HIV diagnosis.
Conclusions Early health screening and implementation of mental health services within HIV treatment improve psychiatric outcomes and ART adherence.
References
2. Nedelcovych MT, Manning AA, Semenova S, Gamaldo C, Haughey NJ, Slusher BS. The Psychiatric Impact of HIV. ACS Chem Neurosci. 2017 Jul 19;8(7):1432-1434. doi: 10.1021/acschemneuro.7b00169. Epub 2017 May 24. PMID: 28537385; PMCID: PMC5769465.
3. Owe-Larsson B, Säll L, Salamon E, Allgulander C. HIV infection and psychiatric illness. Afr J Psychiatry (Johannesbg). 2009 May;12(2):115-28. doi: 10.4314/ajpsy.v12i2.43729. PMID: 19582313.
4. Cilliers K, Muller CJF. Effect of human immunodeficiency virus on the brain: A review. Anat Rec (Hoboken). 2021 Jul;304(7):1389-1399. doi: 10.1002/ar.24573. Epub 2020 Dec 10. PMID: 33231355.
5. Eller LS, Rivero-Mendez M, Voss J, Chen WT, Chaiphibalsarisdi P, Iipinge S, Johnson MO, Portillo CJ, Corless IB, Sullivan K, Tyer-Viola L, Kemppainen J, Rose CD, Sefcik E, Nokes K, Phillips JC, Kirksey K, Nicholas PK, Wantland D, Holzemer WL, Webel AR, Brion JM. Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIV. AIDS Care. 2014;26(7):795-803. doi: 10.1080/09540121.2013.841842. Epub 2013 Oct 4. PMID: 24093715; PMCID: PMC4259284.
6. https://www.who.int/news-room/fact-sheets/detail/depression
7. https://icd.who.int/browse10/2019/en#/F32
8. Rezaei S, Ahmadi S, Rahmati J, Hosseinifard H, Dehnad A, Aryankhesal A, Shabaninejad H, Ghasemyani S, Alihosseini S, Bragazzi NL, Raoofi S, Kiaee ZM, Ghashghaee A. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care. 2019 Dec;9(4):404-412. doi: 10.1136/bmjspcare-2019-001952. Epub 2019 Sep 19. PMID: 31537580.
9. Harsanyi S, Kupcova I, Danisovic L, Klein M. Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? Int J Mol Sci. 2022 Dec 29;24(1):578. doi: 10.3390/ijms24010578. PMID: 36614020; PMCID: PMC9820159.
10. Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: A meta-analysis. J Affect Disord. 2020 Dec 1;277:940-948. doi: 10.1016/j.jad.2020.09.025. Epub 2020 Sep 11. PMID: 33065836.
11. Mudra Rakshasa-Loots A, Whalley HC, Vera JH, Cox SR. Neuroinflammation in HIV-associated depression: evidence and future perspectives. Mol Psychiatry. 2022 Sep;27(9):3619-3632. doi: 10.1038/s41380-022-01619-2. Epub 2022 May 26. PMID: 35618889; PMCID: PMC9708589.
12. Brown MJ, Gao C, Kaur A, Qiao S, Li X. Social Support, Internalized HIV Stigma, Resilience and Depression Among People Living with HIV: A Moderated Mediation Analysis. AIDS Behav. 2023 Apr;27(4):1106-1115. doi: 10.1007/s10461-022-03847-7. Epub 2022 Sep 12. PMID: 36094638; PMCID: PMC10115436.
13. Turan B, Rice WS, Crockett KB, Johnson M, Neilands TB, Ross SN, Kempf MC, Konkle-Parker D, Wingood G, Tien PC, Cohen M, Wilson TE, Logie CH, Sosanya O, Plankey M, Golub E, Adimora AA, Parish C, Weiser SD, Turan JM. Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression. AIDS. 2019 Mar 1;33(3):571-576. doi: 10.1097/QAD.0000000000002071. PMID: 30702521; PMCID: PMC6362840.
14. https://www.who.int/news-room/fact-sheets/detail/post-traumatic-stress-disorder
15. https://www.ptsd.va.gov/professional/treat/essentials/dsm5_ptsd.asp#one
16. Hou J, Fu J, Meng S, Jiang T, Guo C, Wu H, Su B, Zhang T. Posttraumatic Stress Disorder and Nonadherence to Treatment in People Living With HIV: A Systematic Review and Meta-analysis. Front Psychiatry. 2020 Aug 19;11:834. doi: 10.3389/fpsyt.2020.00834. PMID: 32973579; PMCID: PMC7466667.
17. https://www.who.int/news-room/fact-sheets/detail/anxiety-disorders
18. Ji J, Zhang Y, Ma Y, Jia L, Cai M, Li Z, Zhang T, Guo C. People who living with HIV/AIDS also have a high prevalence of anxiety disorders: a systematic review and meta-analysis. Front Psychiatry. 2024 Feb 6;15:1259290. doi: 10.3389/fpsyt.2024.1259290. PMID: 38380124; PMCID: PMC10877523.
19. Shan Y, Sun G, Ji J, Li Z, Chen X, Zhang X, Ma Y, Zhang Y, Zhang T, Zhang Y. Brain function abnormalities and neuroinflammation in people living with HIV-associated anxiety disorders. Front Psychiatry. 2024 Mar 18;15:1336233. doi: 10.3389/fpsyt.2024.1336233. PMID: 38563030; PMCID: PMC10984160.
20. Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, Mayer KH, Moore RD, Mugavero MJ, Napravnik S, Rodriguez B, Donovan DM. Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS Behav. 2017 Apr;21(4):1138-1148. doi: 10.1007/s10461-016-1584-6. PMID: 27738780; PMCID: PMC6089366.
21. Lier AJ, Tarfa A, Shenoi SV, Kuo I, Springer SA. HIV and Substance Use Disorders. Infect Dis Clin North Am. 2024 Sep;38(3):599-611. doi: 10.1016/j.idc.2024.06.003. Epub 2024 Jul 2. PMID: 38960783; PMCID: PMC11410345.
22. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-substance-use
23. Fanucchi L, Springer SA, Korthuis PT. Medications for Treatment of Opioid Use Disorder among Persons Living with HIV. Curr HIV/AIDS Rep. 2019 Feb;16(1):1-6. doi: 10.1007/s11904-019-00436-7. PMID: 30684117; PMCID: PMC6420833.
24. Bizuneh, G.K., Bayleyegn, Z.W., Dagnew, A.D. et al. Impact of alcohol use disorder on antiretroviral therapy adherence in adults with HIV/AIDS at University of Gondar, Northwest Ethiopia. Sci Rep 14, 29745 (2024). https://doi.org/10.1038/s41598-024-79406-y
25. Reiner BC, Keblesh JP, Xiong H. Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol. 2009 Sep 25;1(2):162-179. PMID: 20411028; PMCID: PMC2856939.
26. https://www.emro.who.int/asd/health-topics/drug-related-harm-reduction.html
27. Wang Y, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, Lu L, Bao Y. Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis. Neurology. 2020 Nov 10;95(19):e2610-e2621. doi: 10.1212/WNL.0000000000010752. Epub 2020 Sep 4. PMID: 32887786.
28. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I; CHARTER Group. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 Sep 10;25(14):1747-51. doi: 10.1097/QAD.0b013e32834a40cd. PMID: 21750419; PMCID: PMC3867631.
29. Psychiatria Polska 2013, tom XLVII, numer 3, strony 453–462
30. Elendu C, Aguocha CM, Okeke CV, Okoro CB, Peterson JC. HIV-related neurocognitive disorders: Diagnosis, Treatment, and Mental Health Implications: A Review. Medicine (Baltimore). 2023 Oct 27;102(43):e35652. doi: 10.1097/MD.0000000000035652. PMID: 37904369; PMCID: PMC10615506.
31. Bradley N. Gaynes, Julie O’Donnell, Elise Nelson, Amy Heine, Anne Zinski, Malaika Edwards, Teena McGuinness, Modi A. Riddhi, Charita Montgomery, Brian W. Pence, Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential, General Hospital Psychiatry, Volume 37, Issue 4, 2015, Pages 277-282, ISSN 0163-8343, https://doi.org/10.1016/j.genhosppsych.2015.03.021. (https://www.sciencedirect.com/science/article/pii/S0163834315000651)
32. Arish Mudra Rakshasa-Loots, Depression and HIV: a scoping review in search of neuroimmune biomarkers, Brain Communications, Volume 5, Issue 5, 2023, fcad231, https://doi.org/10.1093/braincomms/fcad231
33. Conteh NK, Latona A, Mahomed O. Mapping the effectiveness of integrating mental health in HIV programs: a scoping review. BMC Health Serv Res. 2023 Apr 24;23(1):396. doi: 10.1186/s12913-023-09359-x. PMID: 37095471; PMCID: PMC10127013.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marta Czechowicz, Joanna Madoń, Patryk Gadziński

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 39
Number of citations: 0